Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$13.89 - $15.04 $1.45 Million - $1.57 Million
104,543 New
104,543 $1.45 Million
Q4 2022

Mar 06, 2023

SELL
$12.42 - $15.62 $7,576 - $9,528
-610 Reduced 19.52%
2,515 $37,000
Q3 2022

Nov 02, 2022

SELL
$12.8 - $28.65 $486 - $1,088
-38 Reduced 1.2%
3,125 $38,000
Q2 2022

Aug 12, 2022

SELL
$13.12 - $15.03 $69,785 - $79,944
-5,319 Reduced 62.71%
3,163 $43,000
Q1 2022

May 13, 2022

BUY
$13.54 - $15.35 $80,089 - $90,795
5,915 Added 230.42%
8,482 $119,000
Q4 2021

Feb 14, 2022

SELL
$13.17 - $16.4 $10,707 - $13,333
-813 Reduced 24.05%
2,567 $33,000
Q3 2021

Nov 12, 2021

BUY
$16.3 - $17.26 $10,937 - $11,581
671 Added 24.77%
3,380 $54,000
Q2 2021

Aug 10, 2021

BUY
$16.55 - $18.64 $2,317 - $2,609
140 Added 5.45%
2,709 $45,000
Q1 2021

May 11, 2021

BUY
$16.71 - $19.9 $9,992 - $11,900
598 Added 30.34%
2,569 $46,000
Q4 2020

Feb 12, 2021

SELL
$15.39 - $18.97 $10,957 - $13,506
-712 Reduced 26.54%
1,971 $35,000
Q3 2020

Nov 13, 2020

BUY
$17.1 - $19.19 $10,670 - $11,974
624 Added 30.31%
2,683 $47,000
Q2 2020

Aug 12, 2020

SELL
$14.59 - $19.5 $8,097 - $10,822
-555 Reduced 21.23%
2,059 $37,000
Q1 2020

May 12, 2020

SELL
$13.02 - $20.31 $201,211 - $313,870
-15,454 Reduced 85.53%
2,614 $40,000
Q4 2019

Feb 07, 2020

SELL
$16.88 - $20.83 $16,576 - $20,455
-982 Reduced 5.15%
18,068 $357,000
Q3 2019

Nov 12, 2019

BUY
$16.15 - $17.99 $8,704 - $9,696
539 Added 2.91%
19,050 $327,000
Q2 2019

Aug 09, 2019

SELL
$16.58 - $20.49 $682,698 - $843,696
-41,176 Reduced 68.99%
18,511 $328,000
Q1 2019

May 10, 2019

BUY
$16.7 - $21.52 $996,772 - $1.28 Million
59,687 New
59,687 $1.22 Million

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $43.1B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Rockefeller Capital Management L.P. Portfolio

Follow Rockefeller Capital Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Rockefeller Capital Management L.P. with notifications on news.